V Research Note: Priced as if the network cannot be dented

The V research family (page counts are those of the approved PDF editions, which this site does not host):

• Deep Dive: A great network, and a price that already assumes it stays one (50 pages). Public preview; the Deep Dive page says how to read the full report.
• Research Note: Priced as if the network cannot be dented (8 pages).
• Technical Appendix: The model's annual schedules (8 pages).
• Learning Companion: How to read the Visa research (14 pages).

---

Valuation date and rating price 11-02-2026; latest settled close 11-09-2026; evidence through 11-09-2026.

The decision

Visa is an excellent business, and at $425.51 we think the shares already say so. Fiscal 2026 net revenue was $45.9 billion, up 14.8%, at a 61.2% GAAP operating margin, and the shares closed 18.4% above their fiscal year-end level, at 32.1 times adjusted earnings. Our reference case, an illustrative reference case that gives the other readings something to be measured against, values an as-converted class A share at $365.04, 14.2% below the price. The exit-multiple check and the owner-earnings reading also land below the price, 4.5% and 21.8% below it, so every central reading at our own settings is below it. The reference reaches the price at a cost of capital of 8.34% alone, or when the two relaxations we tested, a cost of capital of 8.62% and a five-year fade of growth after fiscal 2031, are applied together; neither relaxation alone gets there. The upside case, which is above the price, is a conditional case that bounds the range and not a central reading. Our rating is 3 of 5, BALANCED. The reference value does not reach the price, but the gap is made mostly of two judgments we cannot yet source, the cost of capital and the path of growth after fiscal 2031, rather than of Visa's operating forecast, and we weight them so that the price broadly reflects the opportunity and the risks. The value we compute is one thing, the rating is our judgment of the price against it, and how the shares trade over the next twelve months is a third question that this research does not forecast; the rating is not a forecast that the shares rise or fall, and not a verdict on the business.

The shape of the cases carries as much of the argument as their center. Our downside is an enduring impairment of the network's earning power, not a recession, and it is worth $237.26, 44.2% below the price. Our upside, which keeps volume growth near the fiscal 2026 pace and adds two and a half points of operating leverage, is worth $462.33, only 8.7% above it. The cases are conditional and unweighted; they carry no probabilities. But at our own rate, a price that sits close to the top of the range of cases leaves more to lose than to gain.

Since the valuation date

The latest settled close, the November 9, 2026 regular-session closing price, was $422.16, which is $3.35 or 0.8% below the $425.51 close at which we value and rate Visa. Against it the reference case of $365.04 is 13.5% below, where it was 14.2% below at the valuation close; the downside of $237.26 is 43.8% below, against 44.2%; and the upside of $462.33 is 9.5% above, against 8.7%. The close still sits inside the range of the cases and above the reference. The cost of capital at which the reference would match the close is 8.38%, against 8.34% at the valuation close and the model's 9.06%, a conditional break-even and not a view of what investors believe. The ten-year Treasury par yield was 4.86% on 11-06-2026, the last date in our Treasury table and five basis points below the 4.91% the model uses, and we have not rebuilt the rate. The values are those of 11-02-2026, not rolled forward, and the comparison does not change our reading, which stays 3 of 5, BALANCED, assessed at the valuation close. The annual report filed 11-05-2026 agrees with the figures we used and does not give the pricing share of value-added services growth.

The evidence that decides it

Three facts about fiscal 2026 do most of the work. Growth was fast: net revenue rose from $40.0 billion to $45.9 billion, and fourth-quarter growth of 13.2% showed it already easing from the full-year rate. Growth was also richer than the volume underneath it. Payments volume and processed transactions each grew about 9% in constant dollars, while data processing revenue grew 16.9%, helped by pricing changes and value-added services. The staff of the Securities and Exchange Commission asked the company to quantify them, and the annual report filed 11-05-2026 still does not say how much of the growth is price. And cash was returned faster than it was earned: $25.6 billion went out in repurchases and dividends against $22.1 billion of free cash flow, a payout of 116%, with the balance coming from cash and from the litigation escrow.

Visa's own outlook for fiscal 2027, in its results deck of 10-27-2026, is for the year's net revenue growth and operating expense growth in the low double digits and diluted earnings per share growth in the low double digits to the low teens, all on a non-GAAP adjusted constant-dollar basis. That is company guidance on a basis that differs from our nominal model, which also charges a recurring legal cost the adjusted basis leaves out, so we do not equate the two; as a rough and approximate check only, our reference path's net revenue growth of 11.5% in fiscal 2027 is not at odds with it, and we changed no forecast. Detail the company gave only on its earnings call, such as the expected tax rate and the growth of client incentives, is in no primary document we hold.

The legal position is the other piece. Covered interchange litigation is paid from an escrow whose deposits retire shares of Visa's class B stock, so the cost falls mainly on that stock and not on class A holders. At the 11-02-2026 close the class B buffer was worth $40.1 billion, 2.3 times the $17.4 billion of interchange at issue in May (2.5 times the $15.9 billion the annual report gives for 10-01-2026), and that is why our model charges class A holders no covered-litigation cash. The Department of Justice's debit antitrust case is outside that arrangement, and we have no update on it after June 2025. We carry a recurring allowance for ordinary uncovered legal costs of 1.0% of net revenue in the reference, an assumption anchored on fiscal 2026 and not an estimate for the debit case, and a $5 billion hypothetical charge in the downside, which is the only place the debit case enters the model.

What eight years of reported results show

The record is long enough to separate the network from the noise. Over fiscal 2019 to 2026 net revenue compounded at 10.4% a year and grew in every year from fiscal 2020 to 2026 except the pandemic year, and free cash flow compounded at 9.0%. The margin tells a more careful story: GAAP operating margin fell from 65.3% to 61.2%, but with the litigation provision added back it went from 67.0% to 65.1%, so a little over half of the apparent decline is litigation and the rest is cost growth. The clearest cost of the franchise is what Visa pays its clients. Incentives rose from 21.2% to 28.5% of gross revenue and grew faster than gross revenue in each of the seven years, so net revenue per dollar of payments volume rose only from 0.267% to 0.299% while gross revenue per dollar rose from 0.338% to 0.419%. The scale is not in doubt: on the Nilson Report data in Visa's annual report, Visa carried $14.6 trillion of payments in calendar 2025, 56.3% of the total of the five card networks in that table, and Mastercard's operating margin of 57.6% was 2.4 points below Visa's 60.0% for fiscal 2025 (calendar 2025 against fiscal 2025; Visa's figure includes a litigation provision). Over the eight years Visa returned 97.8% of its free cash flow to shareholders, but in each of the last three years it returned more than it earned, and net debt, measured as debt less cash and cash equivalents, rose from $4.2 billion to $9.1 billion.

What we think the price is paying for

Value is mostly about what happens after fiscal 2031: the terminal value is 80.9% of the reference enterprise value. At our 9.06% cost of capital the reference sits 14.2% below the price. It becomes roughly neutral only if the cost of capital is 8.34%, or terminal growth 4.82%, or growth runs 3.98 percentage points a year faster than our reference in volume, transactions and cross-border flows in every forecast year. Those are break-even combinations, conditional on everything else staying at the reference; they are not what investors believe or what the price requires. The first of them is the one worth weighing, because it is an input we have judged and not measured.

The bull case and the bear case

The strongest case that we are too low is that the reference lets net revenue growth fall to 8.4% in fiscal 2031 and then to 4.0%, below the slowest of the seven growth years we observe outside the pandemic year, 10.0%, and discounts it at a rate built on inputs we could not source. On that reading the upside case of $462.33, or $512.01 at a cost of capital of 8.62%, is the better guide. The strongest case that we are not low enough is that clients' share of the revenue has risen in each of the seven years we observe, adjusted costs grew faster than revenue in fiscal 2026, payouts have run ahead of cash, and the Department of Justice debit case has no reported development since June 2025. On that reading the downside of $237.26, or $309.23 with an unfavorable rate and a slower path, is the better guide. The record supports the trends the bear case cites more than it supports the assumptions the bull case needs, and it settles neither, which is why we show both, with the model's value under each, in the Deep Dive.

What the rating rests on

An independent challenge found that the gap between the reference and the price is built mostly from two judgments and not from Visa's economics, and that is what our rating rests on. Our beta of 0.90 and equity risk premium of 4.75% sit above public readings we found but have not registered as evidence; at 0.85 and 4.50% the cost of capital is 8.62% and the reference would be $399.88, 6.0% below the price. The reference also steps growth from 8.4% to 4.0% in a single year after fiscal 2031, which nothing we hold supports or refutes; a five-year fade alone would lift it to $389.79, 8.4% below. Together the two relaxations give $427.57, 0.5% above the price, and the model meets the price at a cost of capital of 8.34% against our 9.06%. These are sensitivities we have not adopted, and the reference stays at $365.04. We weight the two unsourced judgments so that the price broadly reflects the opportunity and the risks, which is what 3 of 5 means on the Blockhaven scale. It is not a claim that the price equals the value.

The strongest argument against us

The strongest argument against us is that the shares deserve 2 of 5, CAUTIOUS. Neither relaxation has evidence behind it in what we hold, so adopting both to reach the price would mean choosing assumptions for where they put the value. Every central reading at our own settings sits below the price, including the one reading we built from different inputs, a capitalization of fiscal 2026 owner earnings with reinvestment tied to the return on new capital, which gave $332.72, below the reference and not above it. And the asymmetry remains: the lower rate that brings the value close to the price also raises the upside case to $512.01 while lifting the downside only to $255.80, so the range narrows to 39.9% below against 20.3% above and does not turn even. We take that reading seriously, and a reader who weighs the central readings at our own settings above the unsourced judgments would reasonably reach it. We stay at 3 of 5 because nothing we hold shows our own rate or the abrupt step to 4.0% to be the right settings either.

What changes the assessment

The most useful new fact remains the share of fiscal 2026 value-added services growth that came from price, which the annual report filed 11-05-2026 did not give; a small share would make our yield assumptions look cautious. Developments in the Department of Justice case, or a court or regulator changing how debit and credit transactions may be priced or routed, would bear on the downside. Captured, dated sources for beta and the equity premium would settle our largest uncertainty, in either direction, and evidence on how long volume and yield growth stay above 4.0% after fiscal 2031 would settle the second. A materially different share price would change the rating on arithmetic alone. Dated events to watch: the dividend of $0.780 goes to holders of record on 11-10-2026 and is paid 12-01-2026, and the $2.4 billion BioCatch acquisition is expected to complete by the end of fiscal 2027's second quarter.

Assumptions and disclosure

Fiscal 2026 net revenue, operating expenses, net income and earnings per share agree with the annual report filed 11-05-2026, whose statements carry an auditor's report; the model's other fiscal 2026 lines are from the earnings release dated 10-27-2026. The risk-free rate is the official Treasury par yield for 11-02-2026; beta and the equity premium are our judgments; repurchases in the 32 days after 09-30-2026 use the fiscal 2026 pace, and no repurchase after the price date is credited; we do not know the pricing share of services growth, the call-only detail of the fiscal 2027 outlook (the deck's guidance is set out above), or any damages estimate for unresolved claims. No analyst consensus is used. This is research and not personalized advice.

Important disclosures

Blockhaven research is provided for general informational and educational purposes. It is not individualized investment advice and does not take into account any reader's financial circumstances, investment objectives, risk tolerance, tax situation or portfolio.

Nothing in this report is an offer or a solicitation to buy or sell a security or other financial instrument. Reading or accessing Blockhaven research does not by itself create an investment-advisory, fiduciary, brokerage or client relationship.

Investing involves risk, including the possible loss of principal. Scenario values, terminal values, valuation ranges, sensitivities and forward-looking assumptions are analytical tools, not guarantees or promises of future performance, and actual results may differ materially.

Blockhaven uses information from company filings, company publications, market-data providers and other sources it believes to be reliable, but that information may be incomplete, delayed, revised or incorrect.

Opinions, ratings and interpretations reflect Blockhaven's research judgment as of the report date and may change as new evidence becomes available.

Positions and conflicts

As of November 6, 2026, Blockhaven's owner held no shares, options, or other direct derivatives in Visa Inc.; had no material positions in Visa Inc. through entities the owner controls; and had no paid financial relationships with Visa Inc.

© 2026 Blockhaven LLC. All rights reserved.